Print  |  Close

Surgical Thromboprophylaxis Practices in Oncology Patients within the NCORP Network, STOP-VTE Study


Active: Yes
Cancer Type: NCT ID: NCT07215624
Trial Phases: Protocol IDs: WF-2502CD (primary)
WF-2502CD
WF-2502CD
NCI-2025-06376
Eligibility: 18 Years and older, Male and Female Study Type: Health services research
Study Sponsor: Wake Forest NCORP Research Base
NCI Full Details: http://clinicaltrials.gov/show/NCT07215624

Summary

This study evaluates the use of extended venous thromboembolism prophylaxis (ePPX) following abdominopelvic cancer surgery within the NCORP network, targeting surgeons and surgical advanced practice providers (APPs).

Objectives

PRIMARY OBJECTIVE:
I. To evaluate self-reported utilization of guideline concordant extended VTE prophylaxis (ePPx) following abdominopelvic cancer surgery within a sample of surgeons practicing within NCORP based on the Part 1 surgeon survey.

SECONDARY OBJECTIVES:
I. Evaluate site factors (e.g., proportion of publicly insured patients, proportion of Black patients, presence of a medical school, NCI designation) and surgeon factors (e.g., fellowship training, years in practice) associated with surgeon self-reported guideline concordant ePPx utilization (Part 1).
II. Conduct semi-structured interviews among a subset of surgeons and surgical APPs to assess: 1) Barriers/facilitators toward ePPx after cancer surgery and 2) Acceptability of clinical decision support tools to support VTE prophylaxis prescribing (Part 2).
III. Extract EHR data from select practices to assess the feasibility of query-based EHR data extraction for identification of (i) patients undergoing cancer surgery, and (ii) prescription of guideline concordant ePPx among eligible patients (Part 3).

OUTLINE: This is an observational study.

PART 1: Surgeons and APPs complete a survey on study. After completion of surgeon or APP survey, site contact person or CCDR lead complete site surveys on study.

PART 2: A subset of surgeons and APPs from part 1 complete a semi-structured interview on study.

PART 3: Site contact person or CCDR lead complete a survey to identify a EHR Report Specialist on study. EHR Report Specialist performs an EHR Data Extraction and provides feedback on the process in a survey.

Treatment Sites in Georgia

Northside Hospital Cancer Institute
1000 Johnson Ferry Road NE
Atlanta, GA 30342
404-303-3355
www.northside.com

**Clinical trials are research studies that involve people. These studies test new ways to prevent, detect, diagnose, or treat diseases. People who take part in cancer clinical trials have an opportunity to contribute to scientists’ knowledge about cancer and to help in the development of improved cancer treatments. They also receive state-of-the-art care from cancer experts... Click here to learn more about clinical trials.